Government commits $150 million to medical innovation fund

The National Reconstruction Fund Corporation has committed $150 million to Brandon Capital to accelerate Australian medical innovation commercialisation, according to an announcement on Thursday. The investment will be allocated to Brandon Capital’s BioCatalyst 6 fund and will support early and late-stage Australian medical science companies developing therapeutics, medical devices and vaccines. NRFC chief executive David…